Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor

NeuroReport

Volumn 9, Issue 4, 1998, Pages 703-707

  Finberg, John P M ^a   Takeshima, Takao ^b   Johnston, Jane M ^b   Commissiong, John W ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Dopaminergic neurons; GABAergic neurons; Microisland cultures; Neurodegenerative diseases; Neuronal survival; Parkinson's disease; Tissue culture

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; CLORGYLINE; METHAMPHETAMINE; MICROTUBULE ASSOCIATED PROTEIN 2; MONOAMINE OXIDASE B INHIBITOR; RASAGILINE; SELEGILINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; IMMUNOCYTOCHEMISTRY; MESENCEPHALON; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0032498811     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199803090-00026     Document Type: Article

References (23)

1. Tatton WG, Wadia JS, Ju WYH et al. J Neural Transm Suppl 48, 45-59 (1996).
2. Olanow CW, Hauser RA, Gauger L et al. Ann Neurol 38, 771-777 (1995).
3. Fahn S. Adv Neurol 69, 477-486 (1996).
4. Roy E and Bedard PJ. NeuroReport 4, 1183-1186 (1993).
5. Mytilineou C, Radcliffe P, Leonardi EK et al. J Neurochem 68, 33-39 (1997).
6. Koulsilieri E, O'Callaghan JF, Chen TS et al. Eur J Pharmacol 269, R3-4 (1994).
7. Mytilineou C and Cohen G. J Neurochem 45, 1951-1953 (1985).
8. Ansari KS, Yu PH, Kruck TPA et al. J Neurosci 13, 4042-4053 (1993).
9. Biagini G, Zoli M, Fuxe K et al. NeuroReport 4, 955-958 (1993).
10. Finberg JPM, Lamensdorf I, Commissiong JW et al. J Neural Transm Suppl 48, 95-101 (1996).
11. Shimoda K, Sauve Y, Marini A et al. Brain Res 586, 319-331 (1992).
12. Takeshima T, Johnston JM and Commissiong JW. J Neurosci 14, 4769-4779 (1994).
13. Takeshima T, Johnston JM and Commissiong JW. Neurosci Lett 166, 178-182 (1994).
14. Takeshima T, Shimoda K, Johnston JM et al. J Neurosci Methods 67, 27-41 (1996).
15. Yu PH, Davis BA and Zhang X. Prog Brain Res 106, 113-121 (1995).
16. Westlund KN, Krakower TJ, Kwan S-W et al. Brain Res 612, 221-230 (1993).
17. Iwasaki Y, Ikeda A, Shiojima T et al. J.Neurol Sci 125, 11-13.
18. Oh C, Murray B, Bhattacharya N et al. J Neurosci Res 38, 64-74 (1994).
19. Altar CA, Wiegand SJ, Lindsay RM et al. Neurotrophic factors: towards a restorative therapy of Parkinson's disease. In. Olanow CW, Jenner P and Youdim M, eds. Neurodegeneration and Neuroprotection in Parkinson's Disease. London: Academic Press, 1996: 159-185.
20. Bowers WJ, Howard DF and Federoff HJ. Exp Neurol 144, 58-68 (1997).
21. Horellou P, Sabate O, Buc-Caron MH et al. Exp Neurol 144, 131-138 (1997).
22. Raymond HK, Thode S and Gage FH. Exp Neurol 144, 82-91 (1997).
23. Olanow CW. J Neural Transm 91, 161-180 (1993).